Authors' reply to Elshimy

Affiliations

¹ Division of Applied Medicine, Aberdeen University, Aberdeen, UK a.d.ormerod@abdn.ac.uk.
² Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.

Comment

Anthony D Ormerod et al. BMJ. 2015.

. 2015 Sep 30:351:h5115.

doi: 10.1136/bmj.h5115.

¹ Division of Applied Medicine, Aberdeen University, Aberdeen, UK a.d.ormerod@abdn.ac.uk.
² Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.

No abstract available

Comment on

Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston GA, Williams HC; UK Dermatology Clinical Trials Network’s STOP GAP Team. Ormerod AD, et al. BMJ. 2015 Jun 12;350:h2958. doi: 10.1136/bmj.h2958. BMJ. 2015. PMID: 26071094 Free PMC article. Clinical Trial.
Three questions about study on treatments for pyoderma gangrenosum.
Elshimy N. Elshimy N. BMJ. 2015 Sep 30;351:h5113. doi: 10.1136/bmj.h5113. BMJ. 2015. PMID: 26424486 No abstract available.